RecruitingNCT06366815
phenotypeS in Non Ambulant Duchenne Muscular Dystrophy
Characterizing Phenothypes in Non Ambulant Duchenne Muscular Dystrophy
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Enrollment
250 participants
Start Date
Aug 30, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
The aims of the study are to prospectively collect information on several aspects of function in non-ambulant DMD patients by using a structured battery of tests including motor, respiratory and cardiac function
Eligibility
Sex: MALEMin Age: 8 YearsMax Age: 35 Years
Inclusion Criteria1
- Children with genetically confirmed diagnosis of Duchenne Muscular Dystrophy will be included in the study. We will include all Duchenne Muscular Dystrophy boys who have lost the ability to walk independently.
Exclusion Criteria2
- Patients lacking genetic confirmation of Duchenne Muscular Dystrophy
- Patients still able to walk for more than 10 meters.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERDifferent Phenotypes of non ambulant patients with Duchenne Muscular Dystrophy
clinical and functional data collection of non ambulant patients with Duchenne muscular dystrophy
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06366815
Related Trials
Phase 2 Study of SAT-3247 in Pediatric Ambulatory Patients
NCT0728718919 locations
Epithelioid Haemangioendothelioma Observational Study
NCT066804011 location
A Study to Assess the Efficacy and Safety of Satralizumab in Duchenne Muscular Dystrophy (DMD)
NCT0645063925 locations
A Study to Investigate the Safety and Biodistribution of a Single Intrathecal (IT) Injection of INS1201 in Ambulatory Males With Duchenne Muscular Dystrophy (DMD)
NCT068173829 locations
A Phase 1/2 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMN 351 in Participants With Duchenne Muscular Dystrophy
NCT062802098 locations